ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 48229 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 48229; 2) Community: the network communities that were significantly associated with the response to NSC 48229; 3) Molecule: the relationships between components within communities and NSC 48229; 4) MDR: the compounds that were significantly associated with the NSC 48229.

NSC Compound Enrichment Correlation
NSC 679024 1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- 0.00701295499506023 -0.19186457
NSC 684409 18-Norestr-4-en-3-one, 17-ethynyl-13-ethyl- 17.beta.-hydroxy-,2-[(9,10-dihydro-10-oxo-4-acridinyl)carbonyl]hydrazone 0.00701295499506023 -0.15812707
NSC 715407 Null 0.00701295499506023 -0.087549274
NSC 726578 Null 0.00701295499506023 -0.140302
NSC 730009 cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.00701295499506023 -0.16301851
NSC 752346 Null 0.00701295499506023 -0.22547267
NSC 753427 2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol 0.00701295499506023 0.12821434
NSC 756483 SB-742864 0.00701295499506023 -0.14899533
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.00714731931708452 -0.16925733
NSC 363812 Tetraplatin 0.00714731931708452 -0.27129509
Total:111  Current:29    [First] [Prev] [Next] [Last]